Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nonalcoholic fatty liver disease.

Max Bayard1, Jim Holt, Eileen Boroughs

  • 1Department of Family Medicine, East Tennessee State University, Quillen College of Medicine, Johnson City, Tennessee 37604, USA. bayard@mail.etsu.edu

American Family Physician
|June 15, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Syncope: Evaluation and Differential Diagnosis.

American family physician·2023
Same author

Over-the-Counter Medications in Pregnancy.

American family physician·2023
Same author

Identification of origins and influencing factors of environmental odor episodes using trajectory and proximity analyses.

Journal of environmental management·2021
Same author

The origins of the universe: why is there something rather than nothing?

Annals of the New York Academy of Sciences·2015
Same author

Bupropion and restless legs syndrome: a randomized controlled trial.

Journal of the American Board of Family Medicine : JABFM·2011
Same author

Medical decision making: guide to improved CPT coding.

Southern medical journal·2010

Nonalcoholic fatty liver disease (NAFLD) is a common condition linked to metabolic syndrome. While treatments can improve liver enzyme levels and fat accumulation, no current therapies demonstrably enhance patient-oriented outcomes.

Area of Science:

  • Hepatology
  • Metabolic Disorders
  • Internal Medicine

Background:

  • Nonalcoholic fatty liver disease (NAFLD) is a prevalent condition frequently associated with metabolic syndrome.
  • It represents the leading cause of elevated liver enzymes in adults within the United States.
  • Diagnosis involves excluding other causes of hepatic steatosis, such as viral hepatitis and alcohol abuse.

Purpose of the Study:

  • To review the current understanding and management strategies for nonalcoholic fatty liver disease.
  • To highlight diagnostic considerations and treatment approaches for NAFLD.
  • To assess the impact of interventions on patient-oriented outcomes.

Main Methods:

  • Literature review of nonalcoholic fatty liver disease diagnosis and treatment.

Related Experiment Videos

  • Analysis of current therapeutic strategies targeting metabolic abnormalities.
  • Evaluation of evidence regarding treatment efficacy and patient outcomes.

    • Main Results:

    • Liver biopsy may be indicated for specific patient groups, including those with diabetes, morbid obesity, or an AST/ALT ratio > 1, due to higher risks of advanced disease.
    • Weight loss is the cornerstone of treatment for obese individuals with NAFLD.
    • Medications addressing insulin resistance, hyperlipidemia, and obesity can improve liver enzyme levels, steatosis, and histological features.

    Conclusions:

    • Current treatments for NAFLD can ameliorate biochemical and histological markers of liver disease.
    • There is a lack of evidence demonstrating that existing treatments improve patient-centered outcomes.
    • Further research is needed to identify therapies that positively impact long-term patient outcomes in NAFLD.